2020 Q2 Form 10-Q Financial Statement

#000163622220000127 Filed on July 29, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $66.11M $48.56M
YoY Change 36.12% 31.12%
Cost Of Revenue $13.39M $10.57M
YoY Change 26.61% 36.51%
Gross Profit $52.72M $37.99M
YoY Change 38.77% 29.69%
Gross Profit Margin 79.75% 78.23%
Selling, General & Admin $13.38M $13.39M
YoY Change -0.14% 32.9%
% of Gross Profit 25.37% 35.26%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.398M $1.335M
YoY Change 4.72% 23.73%
% of Gross Profit 2.65% 3.51%
Operating Expenses $13.38M $38.28M
YoY Change -65.06% 41.18%
Operating Profit $19.54M $10.29M
YoY Change 89.92% 3.64%
Interest Expense -$4.214M -$4.299M
YoY Change -1.98% 83.56%
% of Operating Profit -21.57% -41.79%
Other Income/Expense, Net
YoY Change
Pretax Income $15.32M $5.988M
YoY Change 155.9% -21.04%
Income Tax $3.800M $1.100M
% Of Pretax Income 24.8% 18.37%
Net Earnings $11.54M $4.918M
YoY Change 134.63% -28.09%
Net Earnings / Revenue 17.46% 10.13%
Basic Earnings Per Share $0.39 $0.17
Diluted Earnings Per Share $0.39 $0.17
COMMON SHARES
Basic Shares Outstanding 29.59M shares 29.42M shares
Diluted Shares Outstanding 29.79M shares 29.67M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.80M $17.10M
YoY Change 167.84% 451.61%
Cash & Equivalents $45.77M $17.08M
Short-Term Investments
Other Short-Term Assets $16.10M $10.80M
YoY Change 49.07% 58.82%
Inventory
Prepaid Expenses
Receivables $5.580M $5.548M
Other Receivables $0.00 $0.00
Total Short-Term Assets $67.46M $33.42M
YoY Change 101.87% 132.59%
LONG-TERM ASSETS
Property, Plant & Equipment $27.22M $8.361M
YoY Change 225.56% 32.13%
Goodwill $50.16M $49.66M
YoY Change 1.02% 3693.35%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.32M $12.32M
YoY Change -8.1% 101.26%
Total Long-Term Assets $133.7M $116.6M
YoY Change 14.62% 6.29%
TOTAL ASSETS
Total Short-Term Assets $67.46M $33.42M
Total Long-Term Assets $133.7M $116.6M
Total Assets $201.1M $150.0M
YoY Change 34.05% 20.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.890M $2.524M
YoY Change 14.5% 32.98%
Accrued Expenses $1.900M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $16.00M $3.200M
YoY Change 400.0% -36.0%
Total Short-Term Liabilities $47.58M $23.86M
YoY Change 99.4% 13.53%
LONG-TERM LIABILITIES
Long-Term Debt $310.8M $308.5M
YoY Change 0.76% 43.78%
Other Long-Term Liabilities $7.038M $8.445M
YoY Change -16.66% 310.55%
Total Long-Term Liabilities $317.9M $317.0M
YoY Change 0.29% 46.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $47.58M $23.86M
Total Long-Term Liabilities $317.9M $317.0M
Total Liabilities $393.8M $366.4M
YoY Change 7.48% 38.38%
SHAREHOLDERS EQUITY
Retained Earnings -$193.0M -$217.6M
YoY Change -11.28% 54.26%
Common Stock $296.0K $295.0K
YoY Change 0.34% 0.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$192.7M -$216.4M
YoY Change
Total Liabilities & Shareholders Equity $201.1M $150.0M
YoY Change 34.05% 20.92%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $11.54M $4.918M
YoY Change 134.63% -28.09%
Depreciation, Depletion And Amortization $1.398M $1.335M
YoY Change 4.72% 23.73%
Cash From Operating Activities $13.14M $890.0K
YoY Change 1376.4% -89.0%
INVESTING ACTIVITIES
Capital Expenditures -$1.090M -$800.0K
YoY Change 36.25% -9.09%
Acquisitions
YoY Change
Other Investing Activities $2.300M $0.00
YoY Change -100.0%
Cash From Investing Activities $1.210M -$800.0K
YoY Change -251.25% -83.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.230M -3.530M
YoY Change -8.5% -29.68%
NET CHANGE
Cash From Operating Activities 13.14M 890.0K
Cash From Investing Activities 1.210M -800.0K
Cash From Financing Activities -3.230M -3.530M
Net Change In Cash 11.12M -3.440M
YoY Change -423.26% 80.1%
FREE CASH FLOW
Cash From Operating Activities $13.14M $890.0K
Capital Expenditures -$1.090M -$800.0K
Free Cash Flow $14.23M $1.690M
YoY Change 742.01% -81.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001636222
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-26
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2020Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.11
CY2020Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.11
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-27
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37425
dei Entity Registrant Name
EntityRegistrantName
WINGSTOP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3494862
dei Entity Address Address Line1
EntityAddressAddressLine1
5501 LBJ Freeway
dei Entity Address Address Line2
EntityAddressAddressLine2
5th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75240
dei City Area Code
CityAreaCode
972
dei Local Phone Number
LocalPhoneNumber
686-6500
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
WING
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29598958 shares
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45766000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12849000 USD
CY2020Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
4132000 USD
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
4790000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5580000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5175000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4118000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2449000 USD
CY2020Q2 wing Advertising Fund Assets Restricted
AdvertisingFundAssetsRestricted
7860000 USD
CY2019Q4 wing Advertising Fund Assets Restricted
AdvertisingFundAssetsRestricted
4927000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
67456000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
30190000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27220000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27842000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
50160000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
50188000 USD
CY2020Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
32700000 USD
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
32700000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11323000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12283000 USD
CY2020Q2 us-gaap Assets
Assets
201114000 USD
CY2019Q4 us-gaap Assets
Assets
166113000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2890000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3348000 USD
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20829000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
21454000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
16000000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3200000 USD
CY2020Q2 wing Advertising Fund Liabilities Restricted
AdvertisingFundLiabilitiesRestricted
7860000 USD
CY2019Q4 wing Advertising Fund Liabilities Restricted
AdvertisingFundLiabilitiesRestricted
4927000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
47579000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32929000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
310846000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
307669000 USD
CY2020Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
22280000 USD
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
22343000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6043000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4485000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7038000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8115000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
393786000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
375541000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29596347 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29596347 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29457228 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29457228 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
296000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
295000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
552000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-193011000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-210275000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-192672000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-209428000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
201114000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
166113000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
27858000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21187000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27504000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
52057000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42515000 USD
CY2020Q2 wing Franchise Advertising Fund Income
FranchiseAdvertisingFundIncome
19923000 USD
CY2019Q2 wing Franchise Advertising Fund Income
FranchiseAdvertisingFundIncome
13487000 USD
wing Franchise Advertising Fund Income
FranchiseAdvertisingFundIncome
35937000 USD
wing Franchise Advertising Fund Income
FranchiseAdvertisingFundIncome
26697000 USD
CY2020Q2 us-gaap Revenues
Revenues
66105000 USD
CY2019Q2 us-gaap Revenues
Revenues
48562000 USD
us-gaap Revenues
Revenues
121541000 USD
us-gaap Revenues
Revenues
96615000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13387000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10573000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24563000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20303000 USD
CY2020Q2 us-gaap Advertising Expense
AdvertisingExpense
18589000 USD
CY2019Q2 us-gaap Advertising Expense
AdvertisingExpense
12973000 USD
us-gaap Advertising Expense
AdvertisingExpense
33513000 USD
us-gaap Advertising Expense
AdvertisingExpense
25707000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13194000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13394000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8709000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15323000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5988000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24649000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13349000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3784000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1070000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5014000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25936000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1398000 USD
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1335000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2953000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2611000 USD
CY2020Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
46568000 USD
CY2019Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
38275000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
88533000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
74557000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
19537000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
10287000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
33008000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
22058000 USD
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4214000 USD
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4299000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8359000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29588000 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1825000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
11539000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
4918000 USD
us-gaap Net Income Loss
NetIncomeLoss
19635000 USD
us-gaap Net Income Loss
NetIncomeLoss
11524000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29418000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29538000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29377000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29793000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29667000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29751000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29650000 shares
CY2020Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.11
CY2019Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.09
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.22
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-224830000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
6606000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
158000 USD
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
833000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
838000 USD
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2571000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-220478000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
4918000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
148000 USD
CY2019Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
226000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1928000 USD
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2658000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-216368000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-209428000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8096000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
505000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
229000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1331000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3223000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-202948000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
11539000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
57000 USD
CY2020Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1969000 USD
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3277000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-192672000 USD
us-gaap Net Income Loss
NetIncomeLoss
19635000 USD
us-gaap Net Income Loss
NetIncomeLoss
11524000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2953000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2611000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1720000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-687000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3300000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2766000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-2016000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
815000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
775000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
405000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-123000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
652000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
678000 USD
wing Increase Decreasein Advertising Fund Assetsand Liabilitiesnet
IncreaseDecreaseinAdvertisingFundAssetsandLiabilitiesnet
2004000 USD
wing Increase Decreasein Advertising Fund Assetsand Liabilitiesnet
IncreaseDecreaseinAdvertisingFundAssetsandLiabilitiesnet
-2664000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-675000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3503000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
10000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-258000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1077000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
482000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25612000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10491000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2670000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1442000 USD
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
2300000 USD
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
0 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20940000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-370000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1442000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
562000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
306000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
16000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
800000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
800000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
241000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1059000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
6500000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
5229000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9021000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6782000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34263000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2267000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21175000 USD
CY2019Q4 us-gaap Senior Notes
SeniorNotes
317600000 USD
CY2020Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
16000000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55438000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23207000 USD
us-gaap Fiscal Period
FiscalPeriod
The Company uses a 52/53-week fiscal year that ends on the last Saturday of the calendar year. Fiscal years 2020 and 2019 each have 52 weeks
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45766000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12849000 USD
CY2020Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
4132000 USD
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
4790000 USD
CY2020Q2 wing Restrictedcashincludedin Advertisingfundassetsrestricted
RestrictedcashincludedinAdvertisingfundassetsrestricted
5540000 USD
CY2019Q4 wing Restrictedcashincludedin Advertisingfundassetsrestricted
RestrictedcashincludedinAdvertisingfundassetsrestricted
3536000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55438000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21175000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29588000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29418000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29538000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29377000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
205000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
249000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
213000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
273000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29793000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29667000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29751000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29650000 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18000 shares
CY2020Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.11
us-gaap Payments Of Dividends
PaymentsOfDividends
6500000 USD
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.22
CY2020Q2 us-gaap Senior Notes
SeniorNotes
316800000 USD
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3800000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.247
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100000 USD
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.179
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000000.0 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.203
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1800000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.137
CY2020Q2 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
200000 USD
us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
1500000 USD
CY2019Q2 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
600000 USD
us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
1800000 USD
CY2020Q2 us-gaap Senior Notes
SeniorNotes
316800000 USD
CY2020Q2 us-gaap Senior Notes
SeniorNotes
316800000 USD
CY2019Q4 us-gaap Senior Notes
SeniorNotes
317600000 USD
CY2020Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
16000000 USD
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2020Q2 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
5954000 USD
CY2019Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
6731000 USD
CY2020Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
326846000 USD
CY2019Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
310869000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
16000000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3200000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
310846000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
307669000 USD
CY2018Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0497
CY2018Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
20000000 USD
CY2020Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
16000000.0 USD
CY2020Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0272
CY2019Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
4000000.0 USD
CY2020Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
4000000.0 USD
us-gaap Debt Instrument Covenant Description
DebtInstrumentCovenantDescription
5.0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
134000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.72
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
10801000 USD
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
67000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
84.41
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
46000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.12
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
155000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
38.02
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
15086000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
200000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2800000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1400000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
400000 USD
CY2020Q2 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2300000 USD
CY2020Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
2000000.0 USD
CY2020Q2 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
28000 USD
CY2020Q2 wing Contractwith Customer Portionof Liabilitynotyetbeing Amortized
ContractwithCustomerPortionofLiabilitynotyetbeingAmortized
8300000 USD
CY2019Q4 wing Contractwith Customer Portionof Liabilitynotyetbeing Amortized
ContractwithCustomerPortionofLiabilitynotyetbeingAmortized
8300000 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P7Y2M12D

Files In Submission

Name View Source Status
0001636222-20-000127-index-headers.html Edgar Link pending
0001636222-20-000127-index.html Edgar Link pending
0001636222-20-000127.txt Edgar Link pending
0001636222-20-000127-xbrl.zip Edgar Link pending
exh31-amendedandrestat.htm Edgar Link pending
exh311ceocertq22020.htm Edgar Link pending
exh312cfocertq22020.htm Edgar Link pending
exh321soxceocertq22020.htm Edgar Link pending
exh322soxcfocertq22020.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wing-20200627.htm Edgar Link pending
wing-20200627.xsd Edgar Link pending
wing-20200627_cal.xml Edgar Link unprocessable
wing-20200627_def.xml Edgar Link unprocessable
wing-20200627_htm.xml Edgar Link completed
wing-20200627_lab.xml Edgar Link unprocessable
wing-20200627_pre.xml Edgar Link unprocessable